MustGrow Biologics Corp. (MGROF)
USD 0.79
(-0.06%)
USD 0.79
(-0.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -210.93 Thousand CAD | 85.58% |
| 2022 | -5.58 Million CAD | -85.37% |
| 2021 | -3.01 Million CAD | 10.63% |
| 2020 | -3.36 Million CAD | -128.86% |
| 2019 | -1.47 Million CAD | 20.56% |
| 2018 | -1.85 Million CAD | -4983.91% |
| 2017 | -36.45 Thousand CAD | -78.31% |
| 2016 | -20.44 Thousand CAD | 96.33% |
| 2015 | -557.61 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.02 Million CAD | 26.8% |
| 2024 Q1 | -1.12 Million CAD | -132.42% |
| 2023 Q1 | -1.04 Million CAD | -4.49% |
| 2023 Q2 | -1.24 Million CAD | -18.9% |
| 2023 Q3 | -1.86 Million CAD | -49.67% |
| 2023 Q4 | 3.46 Million CAD | 286.16% |
| 2023 FY | -804.99 Thousand CAD | 85.58% |
| 2022 Q3 | -2.13 Million CAD | -50.05% |
| 2022 Q1 | -999.58 Thousand CAD | 7.62% |
| 2022 FY | -5.58 Million CAD | -85.37% |
| 2022 Q4 | -1 Million CAD | 53.04% |
| 2022 Q2 | -1.42 Million CAD | -42.21% |
| 2021 Q2 | -646.45 Thousand CAD | -7.73% |
| 2021 Q1 | -600.05 Thousand CAD | 30.68% |
| 2021 FY | -3.01 Million CAD | 10.63% |
| 2021 Q4 | -1.08 Million CAD | -58.51% |
| 2021 Q3 | -682.59 Thousand CAD | -5.59% |
| 2020 Q3 | -614.21 Thousand CAD | 42.22% |
| 2020 FY | -3.36 Million CAD | -128.86% |
| 2020 Q4 | -865.58 Thousand CAD | -40.93% |
| 2020 Q2 | -1.06 Million CAD | -28.61% |
| 2020 Q1 | -826.48 Thousand CAD | -74.18% |
| 2019 Q3 | -398.42 Thousand CAD | -22.26% |
| 2019 Q2 | -325.87 Thousand CAD | -19.21% |
| 2019 Q1 | -273.36 Thousand CAD | -0.81% |
| 2019 FY | -1.47 Million CAD | 20.56% |
| 2019 Q4 | -474.5 Thousand CAD | -19.1% |
| 2018 Q4 | -271.16 Thousand CAD | -27.25% |
| 2018 FY | -1.85 Million CAD | -4983.91% |
| 2018 Q2 | -166.61 Thousand CAD | 82.04% |
| 2018 Q1 | -927.97 Thousand CAD | -2878.7% |
| 2018 Q3 | -213.09 Thousand CAD | -27.89% |
| 2017 Q1 | -33.74 Thousand CAD | 0.0% |
| 2017 Q4 | 33.39 Thousand CAD | 138.83% |
| 2017 Q2 | -67.03 Thousand CAD | -98.65% |
| 2017 FY | -36.45 Thousand CAD | -78.31% |
| 2017 Q3 | -86 Thousand CAD | -28.29% |
| 2016 FY | -20.44 Thousand CAD | 96.33% |
| 2015 FY | -557.61 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Allied Energy Corporation | -314.1 Thousand USD | 32.848% |
| Earth Alive Clean Technologies Inc. | -4.6 Million USD | 95.424% |
| Igene Biotechnology, Inc. | -1.06 Million USD | 80.285% |
| Lotus Bio-Technology Development Corp. | - USD | Infinity% |
| MagIndustries Corp. | -28.77 Million USD | 99.267% |
| Itafos Inc. | 24.56 Million USD | 100.859% |
| Potash America, Inc. | -317.37 Thousand USD | 33.54% |
| Yara International ASA | 415 Million USD | 100.051% |
| Yara International ASA | 430.66 Million USD | 100.049% |